Ascletis Pharma Inc. (HKG:1672)

Ascletis Pharma Revenue

Ascletis Pharma had revenue of 1.08M CNY in the half year ending June 30, 2025, a decrease of -97.68%. This brings the company's revenue in the last twelve months to 2.36M, down -76.57% year-over-year. In the year 2024, Ascletis Pharma had annual revenue of 1.28M, down -97.73%.

• Revenue (ttm): 2.36M CNY
• Revenue Growth: -76.57%
• P/S Ratio: 5,495.17
• Revenue / Employee: 10.23K CNY
• Employees: 231
• Market Cap: 14.23B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.28M	-55.31M	-97.73%
Dec 31, 2023	56.60M	2.51M	4.63%
Dec 31, 2022	54.09M	-22.79M	-29.64%
Dec 31, 2021	76.88M	41.88M	119.64%
Dec 31, 2020	35.00M	-138.44M	-79.82%